Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: Evidence from bench, bedside, and community

European Heart Journal

Volumn 34, Issue 20, 2013, Pages 1506-1516

  Bardai, Abdennasser ^a,b   Amin, Ahmad S ^a   Blom, Marieke T ^a   Bezzina, Connie R ^a   Berdowski, Jocelyn ^a   Langendijk, Pim N J ^a   Beekman, Leander ^a   Klemens, Christine A ^a   Souverein, Patrick C ^c   Koster, Rudolph W ^a   De Boer, Anthonius ^c   Tan, Hanno L ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Electrophysiology; Epidemiology; Ion channels; Nortriptyline; Sudden Death

Indexed keywords

NORTRIPTYLINE; SODIUM CHANNEL;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRUGADA SYNDROME; CONTROLLED STUDY; DEPRESSION; ELECTROCARDIOGRAM; EXERCISE; EXERCISE TEST; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; HEART MUSCLE EXCITABILITY; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QRS COMPLEX; SCN5A GENE; SUDDEN CARDIAC DEATH;

ELECTROPHYSIOLOGY; EPIDEMIOLOGY; ION CHANNELS; NORTRIPTYLINE; SUDDEN DEATH;

ADULT; AGED; CASE-CONTROL STUDIES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; GENE DELETION; HUMANS; MALE; MIDDLE AGED; MUTATION; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL; NORTRIPTYLINE; PROSPECTIVE STUDIES; RISK FACTORS; SODIUM CHANNEL AGONISTS; TACHYCARDIA, VENTRICULAR;

EID: 84878268347     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht054     Document Type: Article

References (35)

1. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Oxford, UK, Elsevier; 2007; p933-974.
2. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482.
3. Eisenberg MS, Mengert TJ. Cardiac resuscitation. N Engl J Med 2001;344: 1304-1313.
4. Amin AS, Tan HL, Wilde AA. Cardiac ion channels in health and disease. Heart Rhythm 2010;7:117-126.
5. Roden DM. Drug-induced prolongation of the QT interval. New Engl J Med 2004; 350:1013-1022.
6. Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, Cappuccio FP, Sagnella GA, Kass RS, Keating MT. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 2002;297:1333-1336.
7. Tan HL, Bardai A, Shimizu W, Moss AJ, Schulze-Bahr E, Noda T, Wilde AA. Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications. Circulation 2006;114:2096-2103.
8. Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, Wilde AA, Escande D, Mannens MM, Le Marec H. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999;23:20-21.
9. Fukuda K, Davies SS, Nakajima T, Ong BH, Kupershmidt S, Fessel J, Amarnath V, Anderson ME, Boyden PA, Viswanathan PC, Roberts LJ 2nd, Balser Jr. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res 2005;97:1262-1269.
10. Greenberg HM, Dwyer EM Jr, Hochman JS, Steinberg JS, Echt DS, Peters RW. Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. Br Heart J 1995;74:631-635.
11. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde AA. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-670.
12. Monteban-Kooistra WE, van den Berg MP, Tulleken JE, Ligtenberg JJ, Meertens JH, Zijlstra JG. Brugada electrocardiographic pattern elicited by cyclic antidepressants overdose. Intensive Care Med 2006;32:281-285.
13. Weeke P, Jensen A, Folke F, Gislason GH, Olesen JB, Andersson C, Fosbøl EL, Larsen JK, Lippert FK, Nielsen SL, Gerds T, Andersen PK, Kanters JK, Poulsen HE, Pehrson S, Køber L, Torp-Pedersen C. Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther 2012;92:72-79.
14. Darbar D, Yang T, Churchwell K, Wilde AA, Roden DM. Unmasking of Brugada syndrome by lithium. Circulation 2005;112:1527-1531.
15. 1000Genomes, http://www.1000genomes.org/; (15 February 2013).
16. Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA. http://evs.gs.washington.edu/EVS/; (15 February 2013).
17. GoNL, http://www.dutchgenomeproject.com/; (15 February 2013).
18. Casini S, Verkerk AO, van Borren MM, van Ginneken AC, Veldkamp MW, de Bakker JM, Tan HL. Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes. Cardiovasc Res 2009;81:72-81.
19. Bezzina CR, Pazoki R, Bardai A, Marsman RF, de Jong JS, Blom MT, Scicluna BP, Jukema JW, Bindraban NR, Lichtner P, Pfeufer A, Bishopric NH, Roden DM, Meitinger T, Chugh SS, Myerburg RJ, Jouven X, Ka?a?b S, Dekker LR, Tan HL, Tanck MW, Wilde AA. Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nature Genet 2010;42:688-691.
20. Bardai A, Berdowski J, van der Werf C, Blom MT, Ceelen M, van Langen IM, Tijssen JG, Wilde AA, Koster RW, Tan HL. Incidence, causes and outcome of out-of-hospital cardiac arrest in children: a comprehensive, prospective, population-based study in The Netherlands. J Am Coll Cardiol: 2011;57: 1822-1828.
21. Pharmo Institute, Utrecht, the Netherlands; available at http://www.pharmo.nl.
22. Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther 2008;33:17-23.
23. Maitland-van der Zee AH, Klungel OH, Stricker BH, van der Kuip DA, Witteman JC, Hofman A, Leufkens HG, de Boer A. Repeated nitrate prescriptions as a potential marker for angina pectoris. A comparison with medical information from the Rotterdam Study. Pharm World Sci 2003;2:70-72.
24. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-349.
25. Shaw RM, Rudy Y. Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res 1997;81:727-741.
26. Simkó J, Szentandra'ssy N, Harmati G, Ba'ra'ndi L, Horva'th B, Magyar J, Ba'nya'sz T, Lorincz I, Na'na'si PP. Effects of ropinirole on action potential characteristics and the underlying ion currents in canine ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 2010;382:213-220.
27. Nattel S, Maguy A, Le Bouter S, Yeh YH. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 2007;87:425-456.
28. Giardina EG, Barnard T, Johnson L, Saroff AL, Bigger JT Jr, Louie M. The antiarrhythmic effect of nortriptyline in cardiac patients with ventricular premature depolarizations. J Am Coll Cardiol 1986;7:1363-1369.
29. Sicouri S, Antzelevitch C. Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf 2008;7:181-194.
30. Sudoh Y, Cahoon EE, Gerner P,Wang GK. Tricyclic antidepressants as long-acting local anesthetics. Pain 2003;103:49-55.
31. Minoura Y, Di Diego JM, Barajas-Marti'nez H, Zygmunt AC, Hu D, Sicouri S, Antzelevitch C. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants. J Cardiovasc Electrophysiol 2012;23:423-432.
32. Casini S, Tan HL, Bhuiyan ZA, Bezzina CR, Barnett P, Cerbai E, Mugelli A, Wilde AA, Veldkamp MW. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation. Cardiovasc Res 2007;76:418-429.
33. Ogata N, Narahashi T. Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes. Br J Pharmacol 1989;97:905-913.
34. Postema PG, Wolpert C, Amin AS, Probst V, Borggrefe M, Roden DM, Priori SG, Tan HL, Hiraoka M, Brugada J, Wilde AA. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www. brugadadrugs.org). Heart Rhythm 2009;6:1335-1341.
35. Baker M. Functional genomics: the changes that count. Nature 2012;482: 259-262.